Journals / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 2

Endoscopic Retrograde Cholangiography and Mirizzi Syndrome: A Single-Center Experience

Pages
178–182
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Examination of the surgical reports of the 22 patients with a preliminary diagnosis of definitive MS based on the ERCP findings revealed that MS was confirmed in 15 patients (68%) and malignancy in 3 patients (14%).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was an investigation of the experience of a single institution with cases of definitive or suspected Mirizzi syndrome (MS) based on endoscopic retrograde cholangiography (ERCP) findings and the correlation of the preliminary diagnosis to the final diagnosis.
📊
Key Findings & Data:Materials and Methods: This retrospective study was performed with the data of 58 patients treated between January 2010 and December 2019.
💡
Conclusion & Impact:Results: Examination of the surgical reports of the 22 patients with a preliminary diagnosis of definitive MS based on the ERCP findings revealed that MS was confirmed in 15 patients (68%) and malignancy in 3 patients (14%).
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study was an investigation of the experience of a single institution with cases of definitive or suspected Mirizzi syndrome (MS) based on endoscopic retrograde cholangiography (ERCP) findings and the correlation of the preliminary diagnosis to the final diagnosis. Materials and Methods: This retrospective study was performed with the data of 58 patients treated between January 2010 and December 2019. Cases where the gallbladder or cystic duct compression of the main hepatic duct was clearly visible as the cause of biliary obstruction were classified in the ERCP report as definitive MS, and those with only a suspicion of compression were reported as suspected MS. In all, 22 patients had a definitive diagnosis of MS and 36 patients had a report of suspected MS. The ERCP reports were compared with surgical reports and the results were analyzed. Results: Examination of the surgical reports of the 22 patients with a preliminary diagnosis of definitive MS based on the ERCP findings revealed that MS was confirmed in 15 patients (68%) and malignancy in 3 patients (14%). No pathology other than gallstones was detected in 4 patients (18%). Review of the surgical reports of the 36 patients with a preliminary diagnosis of suspected MS indicated that MS was detected in 5 patients (14%), malignant stenosis in 20 patients (55%), chronic pancreatitis in 1 patient (3%), and a choledochal cyst in 1 patient (3%). Of the 23 patients with malignancy, cholangiocarcinoma was detected in 16 patients, pancreatic cancer in 3 patients, and gallbladder cancer in 3 patients. Conclusion: The results of this study illustrate the difficulty in accurately diagnosing MS and the frequent confusion with malignancy.

🔖

Cite This Article

PARLAK, E., KAPLAN, M., ÇOŞKUN, O., AKSOY, A., GÖKBULUT, V., KILIÇ, Z. M. Y., ÖDEMİŞ, B., ÖZTAŞ, E., DİŞİBEYAZ, S. (2022). Endoscopic Retrograde Cholangiography and Mirizzi Syndrome: A Single-Center Experience. Erciyes Medical Journal, Cilt: 44 - Sayı: 2, 178–182. https://ajindex.com/articles/502165

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wu CH, Liu NJ, Yeh CN, Wang SY, Jan YY. Predicting cholecystocholedochal fistulas in patients with Mirizzi syndrome undergoing endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2020; 26(40): 6241–9
  2. Ji YF, Gao Y, Xie M. The use of different pathology classification systems in preoperative imaging of Mirizzi syndrome. Arch Med Sci 2019; 15(5): 1288–93
  3. Valderrama-Treviño AI, Granados-Romero JJ, Espejel-Deloiza M, Chernitzky-Camaño J, Barrera Mera B, Estrada-Mata AG, et al. Updates in Mirizzi syndrome. Hepatobiliary Surg Nutr 2017; 6(3): 170–8
  4. Beltran MA, Csendes A, Cruces KS. The relationship of Mirizzi syndrome and cholecystoenteric fistula: validation of a modified classification. World J Surg 2008; 32(10): 2237–43
  5. Roesch-Dietlen F, Pérez-Morales AG, Martínez-Fernández S, RemesTroche JM, Jiménez-García VA, Romero-Sierra G. Mirizzi syndrome: experience at Spanish Hospital of Veracruz. [Article in Spanish]. Cir Cir 2013; 81(3): 232–6
  6. Hassan R, Solinas L, Notarangelo M, Sagnotta A, Giubilo C, Battaglia B, et al. Mirizzi syndrome: a challenging diagnosis. Case report. G Chir 2019; 40(3): 193–8
  7. Payá-Llorente C, Vázquez-Tarragón A, Alberola-Soler A, MartínezPérez A, Martínez-López E, Santarrufina-Martínez S, et al. Mirizzi syndrome: a new insight provided by a novel classification. Ann Hepatobiliary Pancreat Surg 2017; 21(2): 67–75
  8. Clemente G, Tringali A, De Rose AM, Panettieri E, Murazio M, Nuzzo G, et al. Mirizzi syndrome: Diagnosis and management of a challenging biliary disease. Can J Gastroenterol Hepatol 2018; 2018: 6962090
  9. Maĭstrenko NA, Sheĭko SB, Stukalov VV, Ratnikova VA, Basos SF, Kazakevich GG, et al. Modern possibilities to diagnose the Mirizzi syndrome. [Article in Russian]. Vestn Khir Im I I Grek 2009; 168(2): 27–33
  10. Kulikovsky VF, Soloshenko AV, Karpachev AA, Yarosh AL, Vlasyuk YY. Endoscopic interventions in diagnosis and treatment of Mirizzi syndrome. [Article in Russian]. Khirurgiia (Mosk) 2016; (4): 11–4
  11. Jones MW, Ferguson T. Mirizzi syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; Sep 9, 2021
  12. Kulkarni SS, Hotta M, Sher L, Selby RR, Parekh D, Buxbaum J, Stapfer M. Complicated gallstone disease: diagnosis and management of Mirizzi syndrome. Surg Endosc 2017; 31(5): 2215–22
  13. Erben Y, Benavente-Chenhalls LA, Donohue JM, Que FG, Kendrick ML, Reid-Lombardo KM, et al. Diagnosis and treatment of Mirizzi syndrome: 23-year Mayo Clinic experience.